Correlation Between Cannabics Pharmaceuticals and Intellipharmaceutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Intellipharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Intellipharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabics Pharmaceuticals and Intellipharmaceutics International, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Intellipharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Intellipharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Intellipharmaceutics.

Diversification Opportunities for Cannabics Pharmaceuticals and Intellipharmaceutics

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cannabics and Intellipharmaceutics is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Intellipharmaceutics Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellipharmaceutics and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Intellipharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellipharmaceutics has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Intellipharmaceutics go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Intellipharmaceutics

If you would invest  3.80  in Intellipharmaceutics International on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Intellipharmaceutics International or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Cannabics Pharmaceuticals  vs.  Intellipharmaceutics Internati

 Performance 
       Timeline  
Cannabics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Intellipharmaceutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Cannabics Pharmaceuticals and Intellipharmaceutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabics Pharmaceuticals and Intellipharmaceutics

The main advantage of trading using opposite Cannabics Pharmaceuticals and Intellipharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Intellipharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellipharmaceutics will offset losses from the drop in Intellipharmaceutics' long position.
The idea behind Cannabics Pharmaceuticals and Intellipharmaceutics International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges